BRITTANY CANADY: Open Payments
NPI 1336677699 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 25 payments from 9 companies in 2025. Trend: 2023 $309 · 2024 $263 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $178 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| ABBVIE INC. | 3 | $60 |
| Corcept Therapeutics | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Wegovy, BREZTRI, Korlym, Ozempic, AIRSUPRA, VRAYLAR, XIFAXAN, QULIPTA.
Industry payments across NC — which companies pay providers there.
